Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pressure Biosciences (OP: PBIO )

0.2100 -0.0099 (-4.50%)
Streaming Delayed Price Updated: 11:08 AM EDT, May 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pressure Biosciences

< Previous 1 2 3 4 5 6 7 8 Next >
InvestorNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Scalable UST(TM) Process Shown to Create Rock-Solid 18-Month Stability
Via Investor Brand Network
Exposures Product Safety
Pressure BioSciences Shatters Preconceived Nanoemulsion Stability, Performance, and Production Limits: Produces CBD Oil Nanoemulsions with 18 Month Stability
UST Platform's Ultra-low Droplet Sizes and Test Verified Stability Portends Revolution in Major Markets SOUTH EASTON, MA / ACCESSWIRE / December 22, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO)... 
From Pressure BioSciences Inc.
Via AccessWire
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Q3 2021 Financial Report
Via Investor Brand Network
Pressure BioSciences, Inc. Q3 Financial Results Maintain Solid 2021 YTD Growth
Operational and Technical Achievements Set Stage for Expected Major Growth and Profitability in 2022 Investor Call Scheduled for Wednesday, November 17, 2021 at 4:30 p.m. ET SOUTH EASTON, MA /... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Earnings Regulatory Compliance
Exposures Financial Legal Regulatory
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Second US Patent for Innovative UST(TM) Platform, NanoGap(TM) Valve
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Pressure BioSciences Awarded Second U.S. Patent for Its Revolutionary Ultra Shear Technology Platform, for Its Innovative NanoGap Valve
Dynamically-Adaptive Compact Valve is Key Component in the Company's Highly Anticipated and Proprietary UST Platform; UST Expected to Help Deliver Strong Sales Growth and Profitability in 2022 SOUTH... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures Intellectual Property Legal Regulatory
InvestorNewsBreaks – Pressure BioSciences Inc.’s (PBIO) BaroFold Platform Brings Key Capabilities Amid Strong Demand for Protein Therapeutics
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Pressure BioSciences’ BaroFold Platform Unleashes Hidden Growth Engine as Strong Demand for Protein Therapeutics Leverages PBI’s Protein Refolding Technology
Titans and Emerging Leaders of Biopharma Struggling with Protein Misfolding and Aggregation Issues that Threaten Enormous Revenue Potentials Are Turning to PBI's Uniquely Enabling BaroFold Solution... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures Intellectual Property Legal Regulatory
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at First-of-Its-Kind Benzinga ALL ACCESS Investor Event
Via Investor Brand Network
Pressure BioSciences to Participate in the Benzinga ALL ACCESS Investor Event
Company Invites Individual and Institutional Investors, as well as Analysts and Advisors, to Attend Its Live, Virtual Guest Appearance on Thursday, November 4, 2021 SOUTH EASTON, MA / ACCESSWIRE /... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance Supply Chain
Exposures Intellectual Property Legal Regulatory
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Changes Neem Oil into Novel Nanoemulsion through Patented UST Platform
Via Investor Brand Network
Pressure BioSciences UST Platform Successfully Transforms Neem Oil into a Novel, Highly Potent Nanoemulsion for More Effective Agrochemical Applications
Nanoemulsified Neem Oil Droplets Were Designed to Provide Stable, Water-Miscible Concentrates of this Natural, Environmentally Safe Pesticide for Improved Wholesale and Retail Use SOUTH EASTON, MA /... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate in Upcoming Small Cap Conferences
Via Investor Brand Network
Pressure BioSciences Announces Forward Integration Plans for Ultra Shear Technology Demonstration and Toll Manufacturing Partnerships on U.S. West and East Coasts
Company Flooded with Opportunities to Demo Breakthrough UST Nanoemulsion Benefits and Serve Toll Production Demand in Pharmaceutical, Nutraceutical, and Personal Care Applications SOUTH EASTON, MA /... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Pressure BioSciences to Update Investors on Recent Accomplishments, Year-End Goals, Plans for Accelerating Revenue Growth, and Path to Profitability in 2022
Company to Present this Week at the Benzinga Healthcare and Emerging Growth Small Cap Conferences SOUTH EASTON, MA / ACCESSWIRE / September 28, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Pressure BioSciences, Inc. Reports Strong Second Quarter 2021 Financial Results
Significant Growth Reported in Total Revenue (127%), Instrument Sales (178%), and BaroFold/UST Services (298%); Significant Decrease in Operating Loss (51%) Achieved Investor Call Scheduled for... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Earnings Intellectual Property Regulatory Compliance
Exposures Financial Intellectual Property Legal
Pressure BioSciences to Host Q2 2021 Financial Results and Business Update on Thursday, August 19, 2021
Company to Discuss Strong Q2 2021 Financial Results, Give Update on Current Activities, and Take Questions on Aggressive Growth Plan Laid Out for the Company on August 5, 2021 SOUTH EASTON, MA /... 
From Pressure BioSciences Inc.
Via AccessWire
Pressure BioSciences to Expand on Recent Announcement of Over $1,000,000 in Orders Received by its New Eco-Friendly Agrochem Subsidiary in First Month of Operations
Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, Interactive PBI Agrochem Update, Followed by a Q&A Session, on Wednesday, August 18, 2021 SOUTH EASTON, MA / ACCESSWIRE /... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Global Agrochemicals Market Size Expected to Reach $335 Billion in 2026
Via FinancialNewsMedia
Pressure BioSciences New Eco-Friendly Agrochem Subsidiary Receives Over $1,000,000 in Orders in First Month of Operations
Via FinancialNewsMedia
Pressure BioSciences New Eco-Friendly Agrochem Subsidiary Receives Over $1,000,000 in Orders in First Month of Operations
PBI Agrochem Integration into the Sales Channels of Its Planned Asset Acquisition of a Global, Environmentally Responsible Agrochem Company is Expected to Result in a Significant Q3 2021 Impact SOUTH... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Pressure BioSciences Unveils Aggressive Growth Plan and Goals for Second Half 2021; Company Marches Toward UST Commercial Release, Up-listing, and Profitability
Company's Strong First Half 2021 Viewed as Launch Pad for Accelerating Second Half and Growth Trajectory, Propelled by Multiple Platform Technologies Building Market Traction SOUTH EASTON, MA /... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures Intellectual Property Legal Product Safety
Global Cannabidiol Market Size Expected to Reach $2.8 Billion by 2028 with a CAGR of 21%
Via FinancialNewsMedia
Topics Cannabis
Exposures Cannabis
Pressure BioSciences Announces Major Business Expansion, Establishing Eco-Friendly Agrochemicals Subsidiary and Initiating Plans to Drive Accretive 2021 Revenue
Significant Order for Environmentally Friendly Agrochemical Material Placed to Fulfill Initial Demand; Subsidiary will House Announced Asset Acquisition from Global Agrochemicals Innovator SOUTH... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance Supply Chain
Exposures Legal Regulatory Supply Chain
Pressure BioSciences to Expand on Recent UST Platform Breakthroughs and Impending Agrochem Asset Acquisition at Upcoming Emerging Growth Conference
Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, Interactive UST Platform and Agrochem Asset Acquisition Update, Followed by a Q&A Session, on Wednesday, July 21, 2021 SOUTH... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Pressure BioSciences, Inc. Discusses Historic CBD Nanoemulsion Stability Achievement and Astaxanthin Nanoemulsions with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - July 16, 2021) - The Stock Day Podcast welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) ("the Company"),... 
Via Newsfile
Topics Intellectual Property Regulatory Compliance
Exposures Intellectual Property Legal Regulatory
Pressure BioSciences UST-Enabled Nanoemulsions Soar Past One Year Stability Goal; Results Open Explosive Growth Potential for Water-Soluble CBD-Infused Beverages Worldwide
UST Nanoemulsions of CBD Deliver High Water-Solubility and Over One Year Storage Stability with No Degradation; UST Platform Primed to Revolutionize Food & Beverage, Biotherapeutic, Nutraceutical, and... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Cannabis Regulatory Compliance
Exposures Cannabis Legal Regulatory
CBD-Infused Beverages Market Is Expected to Exceed $14 Billion by End of 2026
Via FinancialNewsMedia
Topics Cannabis Derivatives
Exposures Cannabis Derivatives
Pressure BioSciences UST-Enabled Nanoemulsions Soar Past One Year Stability Goal;  Results Open Explosive Growth Potential for Water-Soluble CBD-Infused Beverages Worldwide
Via FinancialNewsMedia
Astaxanthin Market Expected to Exceed $1.2 Billion By 2026 Leading the Nutraceutical Segment for Lucrative Growth
Via FinancialNewsMedia
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.